Supreme Court Affirms Investor's Right To Maintain Oppression Plea Despite No Entry In Register Of Members

The Supreme Court has recently held that an investor can, in certain cases, maintain oppression and mismanagement proceedings under the Companies Act, 1956 even if his name was never entered in the company's register of members, particularly where the company had consistently recognised and treated him as a stakeholder.

“A conjoint reading of Sections 397, 398 and 399 indicates that the expression “member” cannot be construed in isolation or confined to the technical formulation contained in Section 41(2). Rather, the broader definition embodied in Section 2(27) assumes significance in determining whether a person is entitled to invoke the remedies contemplated under the Act," the Court observed.

A bench of Justice Pamidighantam Sri Narasimha and Justice Alok Aradhe dismissed appeals filed by Dr. Bais Surgical and Medical Institute Pvt Ltd and its directors against concurrent findings of the Company Law Board and the High Court in favour of investor Dhananjay Pande.

The Court held that the equitable nature of proceedings under Sections 397 and 398 of the Companies Act, 1956 required the expression “member” to be interpreted broadly instead of being restricted only to persons whose names formally appeared in the register of members.

“The equitable foundation of Sections 397 and 398 must be a guiding factor to not construe the expression “member” in an unduly restrictive or technical manner confined solely to formal entry in the register, thereby frustrating the remedial purpose underlying the legislative scheme.,” the bench said.

The Court further observed that the requirement introduced under Section 41(2) that a person must agree “in writing” to become a member was intended to ensure reliable proof of consent and prevent fraudulent inclusion of names in the register of members, and not to curtail the substantive rights of genuine shareholders or investors.

The dispute arose after the company, which operated a hospital, faced financial difficulties soon after its incorporation in 1994. Dhananjay Pande approached the promoters with a proposal to infuse funds into the company on the condition that he would be appointed Managing Director and that the hospital would be converted into a specialised cardiac facility.

Pande was appointed Managing Director with effect from January 1, 1998, and the hospital was subsequently renamed “Ekvira Heart Institute”, reflecting the name of his trading concern. He later claimed that 14,75,998 shares had been allotted to him against share application money paid by him to the company, although share certificates were never issued.

Disputes later arose between the parties, leading to Pande's suspension from the company and subsequent conciliation proceedings. Upon conclusion of the conciliation proceedings, the suspension order was withdrawn and Pande withdrew from the day-to-day affairs of the company.

In 2001, Pande moved the Company Law Board under Sections 397 and 398 of the Companies Act, 1956 alleging oppression and mismanagement, primarily contending that despite substantial investment in the company, share certificates were never issued to him.

The Company Law Board, by an order passed in 2004, directed the company either to allot shares corresponding to Pande's investment or refund the invested amount with interest. It also held that Pande was entitled to be treated as a member of the company.

During the pendency of the dispute, the company's board allotted 60,00,000 shares to another against the transfer of the hospital property, which Pande challenged in a second petition, alleging that the allotment was intended to dilute his stake from 49% to 15%.

In 2008, the Company Law Board held that the allotment was oppressive in nature and directed the appellants or Wockhardt Hospitals Ltd, which had subsequently entered into a management agreement with the company, to purchase the shares allotted to Pande together with interest.

Both orders were upheld by the Madhya Pradesh High Court, following which the company and its directors approached the Supreme Court.

Before the apex court, Dr. Bais Surgical and Medical Institute Pvt Ltd and its directors argued that Pande could not maintain proceedings under Sections 397 and 398 because his name never appeared in the company's register of members, as contemplated under Section 41 of the Companies Act, 1956.

They also pointed to civil suits earlier filed by Pande seeking recovery of the money invested by him, contending that he had himself treated the amount as a recoverable debt and not as share capital.

The Supreme Court was not persuaded. Examining the record, the bench noted that over the years, the company had consistently treated Pande as someone with a stake in its affairs rather than as a mere creditor.

Among the documents relied upon by the Court was correspondence in which Pande had been described as a “co-owner”, along with conciliation records acknowledging his entitlement to shares.

The court also took note of the company's own financial conduct, as Pande's investment had been accepted, used in the hospital's operations, and had contributed to increased authorised share capital and profitability.

The bench additionally referred to Pande's appointment as Managing Director and the renaming of the hospital as “Ekvira Heart Institute”, drawn from the name of his trading concern.

These circumstances, the Court said, reinforced the conclusion that the company itself had recognised his proprietary stake and participation in its functioning.

Affirming the findings of the Madhya Pradesh High Court and the Company Law Board, the Supreme Court held that Pande was entitled to be treated as a member for the limited purpose of maintaining oppression and mismanagement proceedings under the Companies Act, 1956.

The appeals were dismissed, and the amount deposited before the Court, along with accrued interest, was directed to be released in his favour.